Effect of montelukast in preventing dengue with warning signs among patients with dengue: A multicenter, randomized, double-blind, placebo-controlled trial
ConclusionOral montelukast does not reduce the incidence of warning signs among patients with dengue. Nevertheless, the observed decrease in transaminase elevations warrants further investigation to evaluate the potential effect of montelukast. Clinical Trials RegistrationClinicaltrials.gov, NCT04673422, registered on 9 December 2020
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Nattapat Nitinai Source Type: research
More News: Clinical Trials | Dengue Fever | Statistics | Study | Thailand Health | Thrombocytopenia | Tropical Medicine | Warnings